Skip to content

Study on the application of oral carbohydrate in outpatient patients with direct vision abortion

Study on the application of oral carbohydrate in outpatient patients with direct vision abortion

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000032850
Enrollment
Unknown
Registered
2020-05-13
Start date
2020-06-01
Completion date
Unknown
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

artificial abortion

Interventions

control group:Oral pure water 300-400ml 2h before surgery
experimental group:Oral administration of 300-400ml of clear liquid carbohydrates 2h before surgery

Sponsors

Henan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Healthy women aged between 18 and 45; 2. No pregnancy complications or complications; 3. Days of amenorrhea no more than 70 days; 4. The pregnancy sac diameter is greater than 15 x 15mm, and the embryo is no more than 30mm, and located in utero; 5. Natural childbirth > for 3 months; 6. More than 6 months after normal cesarean section; 7. Days of pregnancy no more than 60 days; 8. For patients with scar uterus, the normal cesarean section history was no more than 2 times, and gynecological color doppler ultrasound indicated that the pregnancy sac was no more than 10mm from the incision; 9. More than 6 months after surgery for uterine fibroids (subserous); 10. Intrauterine pregnancy with ovarian cyst < 5cm and myomyoblastoma diameter < 3cm did not affect uterine cavity morphology; 11. In the case that the embryo stops developing, the number of days of menopause is no more than 70 days (normal menstrual cycle); 12. Sufficient preoperative consultation and communication; willing to participate in this study and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe acute and chronic diseases such as liver, kidney, spleen and coagulation dysfunction; 2. Refusal to sign the informed consent; 3. The clinician judged that who were not suitable for the study; 4. Delayed gastric emptying.

Design outcomes

Primary

MeasureTime frame
HAMA scale;BFI-C scale;blood glucose;VAS scale;

Secondary

MeasureTime frame
vital signs;color ultrasound;nausea;emesis;stomachache;gastric emptying;aspiration;

Countries

China

Contacts

Public ContactZhu Peiru

Henan Provincial People's Hospital

Zhupeirufumen@126.com+86 18538298095

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026